Showing 1 - 20 results of 31 for search 'Meiyu Geng', query time: 0.06s
Refine Results
-
1
Alzheimer’s disease hypothesis and related therapies by Xiaoguang Du, Xinyi Wang, Meiyu Geng
Published 2018-01-01
Article -
2
Chronic Kidney Disease and Cognitive Impairment: The Kidney-Brain Axis by Zuoquan Xie, Siyu Tong, Xingkun Chu, Teng Feng, Meiyu Geng
Published 2022-05-01
Article -
3
Undecylprodigiosin induced apoptosis in P388 cancer cells is associated with its binding to ribosome. by Ping Liu, Yuan-yuan Wang, Xin Qi, QianQun Gu, Meiyu Geng, Jing Li
Published 2013-01-01
Article -
4
-
5
-
6
Discovery of Novel c-Met Inhibitors Bearing a 3-Carboxyl Piperidin-2-one Scaffold by Wei Zhang, Jing Ai, Dakuo Shi, Xia Peng, Yinchun Ji, Jian Liu, Meiyu Geng, Yingxia Li
Published 2014-02-01
Article -
7
A novel STING agonist with systemic and durable anti‐tumour activity by Xiyuan Wang, Ancheng Shen, Yan Zhang, Xiaoxu Chen, Jian Ding, Ao Zhang, Meiyu Geng, Chunyong Ding, Zuoquan Xie
Published 2023-10-01
Article -
8
-
9
-
10
-
11
-
12
-
13
Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patients. by Jiang Zhu, Yu-Nong Wu, Wei Zhang, Xiao-Min Zhang, Xu Ding, Huai-Qi Li, Meiyu Geng, Zuo-Quan Xie, He-Ming Wu
Published 2014-01-01
Article -
14
Discovery of a series of dimethoxybenzene FGFR inhibitors with 5H-pyrrolo[2,3-b]pyrazine scaffold: structure–activity relationship, crystal structural characterization and in vivo... by Peng Wei, Bo Liu, Ruifeng Wang, Yinglei Gao, Lanlan Li, Yuchi Ma, Zhiwei Qian, Yuelei Chen, Maosheng Cheng, Meiyu Geng, Jingkang Shen, Dongmei Zhao, Jing Ai, Bing Xiong
Published 2019-03-01
Article -
15
Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling. by Shuai Wang, Xun Huang, Danni Sun, Xianliang Xin, Qiuming Pan, Shuying Peng, Zhongjie Liang, Cheng Luo, Yiming Yang, Hualiang Jiang, Min Huang, Wengang Chai, Jian Ding, Meiyu Geng
Published 2012-01-01
Article -
16
A novel strategy for treating oncogene‐mutated tumors by targeting tumor microenvironment and synergistically enhancing anti‐PD‐1 immunotherapy by Yingqiang Liu, Linjiang Tong, Mengge Zhang, Qi Zhang, Qiupei Liu, Fang Feng, Yan Li, Mengzhen Lai, Haotian Tang, Yi Chen, Meiyu Geng, Wenhu Duan, Jian Ding, Hua Xie
Published 2024-03-01
Article -
17
HER2/PD1 bispecific antibody in IgG4 subclass with superior anti‐tumour activities by Wendi Chu, Hui Xu, Yanfei Wang, Yongle Xie, Yi‐Li Chen, Xiaorong Tan, Chenghao Huang, Guifeng Wang, Qi Wang, Wenxin Luo, Ningshao Xia, Meiyu Geng, Zuoquan Xie, Chunhe Wang
Published 2022-04-01
Article -
18
Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors by Xiaowei Wu, Mengdi Dai, Rongrong Cui, Yulan Wang, Chunpu Li, Xia Peng, Jihui Zhao, Bao Wang, Yang Dai, Dan Feng, Tianbiao Yang, Hualiang Jiang, Meiyu Geng, Jing Ai, Mingyue Zheng, Hong Liu
Published 2021-03-01
Article -
19
Low‐Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial Cells by Congying Pu, Yize Li, Yixian Fu, Yiyang Yan, Siyao Tao, Shuai Tang, Xiameng Gai, Ziyi Ding, Zhenjie Gan, Yingluo Liu, Siyuwei Cao, Ting Wang, Jian Ding, Jun Xu, Meiyu Geng, Min Huang
Published 2024-03-01
Article -
20
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models by Xia Peng, Pengcong Hou, Yi Chen, Yang Dai, Yinchun Ji, Yanyan Shen, Yi Su, Bo Liu, Yueliang Wang, Deqiao Sun, Yuchen Jiang, Chuantao Zha, Zuoquan Xie, Jian Ding, Meiyu Geng, Jing Ai
Published 2019-08-01
Article